Literature DB >> 4327743

Single dose dexamethasone in treatment of congenital adrenocortical hyperplasia.

A Hayek, J D Crawford, H H Bode.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4327743     DOI： 10.1016/0026-0495(71)90052-7

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

Review 1.  Congenital adrenal hyperplasia.

Authors:  G H Newns
Journal:  Arch Dis Child       Date:  1974-01       Impact factor: 3.791

2.  Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.

Authors:  S M Atherden; N D Barnes; D B Grant
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

3.  A randomized controlled assessment of the effects of different dosing regimens of budesonide on the HPA-axis in healthy subjects.

Authors:  N Andersson; A Källén; L Thorsson
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

4.  Low-dose dexamethasone therapy from infancy of virilizing congenital adrenal hyperplasia.

Authors:  Scott A Rivkees; Kerry Stephenson
Journal:  Int J Pediatr Endocrinol       Date:  2010-01-14

5.  Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the "growth toxic" glucocorticoid.

Authors:  Scott A Rivkees
Journal:  Int J Pediatr Endocrinol       Date:  2010-04-15

6.  Dexamethasone treatment for congenital adrenal hyperplasia.

Authors:  M C Young; I A Hughes
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

7.  Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia.

Authors:  Andrew Dauber; Henry A Feldman; Joseph A Majzoub
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.